Lu, Y; Beeghly-Fadiel, A; Wu, L; Guo, X; Li, B; Schildkraut, JM; et al.(2018). A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research, 78(18), 5419-5430. doi: 10.1158/0008-5472.CAN-18-0951. UCLA: Retrieved from: http://www.escholarship.org/uc/item/8hz7r646
Southey, MC; Goldgar, DE; Winqvist, R; Pylkäs, K; Couch, F; Tischkowitz, M; et al.(2016). PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS. Journal of Medical Genetics, 53(12), 800-811. doi: 10.1136/jmedgenet-2016-103839. UCLA: Retrieved from: http://www.escholarship.org/uc/item/9gn7b78q
Hollestelle, A; Van Der Baan, FH; Berchuck, A; Johnatty, SE; Aben, KK; Agnarsson, BA; et al.(2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141(2), 386-401. doi: 10.1016/j.ygyno.2015.04.034. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2w30z17d